Shengyuan Bai
Publications
ReactBench: A Benchmark for Topological Reasoning in MLLMs on Chemical Reaction Diagrams
Multimodal Large Language Models (MLLMs) excel at recognizing individual visual elements and reasoning over simple linear diagrams. However, when faced with complex topological structures involving branching paths, converging flows, and cyclic dependencies, their reasoning capabilities degrade sharply, even on tasks as basic as counting endpoints. Existing benchmarks fail to probe this gap, focusing on semantic comprehension rather than structural reasoning. We introduce ReactBench, a benchmark that reveals fundamental limitations in structural reasoning through chemical reaction diagrams. These real-world scientific diagrams offer an ideal testbed because they naturally span diverse structures from linear chains to cyclic graphs, while requiring both precise local recognition and coherent global reasoning. Our benchmark comprises 1,618 expert-annotated QA pairs across four hierarchical task dimensions. Extensive evaluation across 17 MLLMs reveals a significant performance gap exceeding 30% between anchor-based tasks and holistic structural reasoning tasks. Controlled ablations confirm this bottleneck lies in reasoning, not perception. These findings expose a fundamental deficit in structural understanding and establish directions for advancing visual reasoning.
Gaze patterns predict preference and confidence in pairwise AI image evaluation
Preference learning methods, such as Reinforcement Learning from Human Feedback (RLHF) and Direct Preference Optimization (DPO), rely on pairwise human judgments, yet little is known about the cognitive processes underlying these judgments. We investigate whether eye-tracking can reveal preference formation during pairwise AI-generated image evaluation. Thirty participants completed 1,800 trials while their gaze was recorded. We replicated the gaze cascade effect, with gaze shifting toward chosen images approximately one second before the decision. Cascade dynamics were consistent across confidence levels. Gaze features predicted binary choice (68% accuracy), with chosen images receiving more dwell time, fixations, and revisits. Gaze transitions distinguished high-confidence from uncertain decisions (66% accuracy), with low-confidence trials showing more image switches per second. These results show that gaze patterns predict both choice and confidence in pairwise image evaluations, suggesting that eye-tracking provides implicit signals relevant to the quality of preference annotations.
Mozi: Governed Autonomy for Drug Discovery LLM Agents
Tool-augmented large language model (LLM) agents promise to unify scientific reasoning with computation, yet their deployment in high-stakes domains like drug discovery is bottlenecked by two critical barriers: unconstrained tool-use governance and poor long-horizon reliability. In dependency-heavy pharmaceutical pipelines, autonomous agents often drift into irreproducible trajectories, where early-stage hallucinations multiplicatively compound into downstream failures. To overcome this, we present Mozi, a dual-layer architecture that bridges the flexibility of generative AI with the deterministic rigor of computational biology. Layer A (Control Plane) establishes a governed supervisor--worker hierarchy that enforces role-based tool isolation, limits execution to constrained action spaces, and drives reflection-based replanning. Layer B (Workflow Plane) operationalizes canonical drug discovery stages -- from Target Identification to Lead Optimization -- as stateful, composable skill graphs. This layer integrates strict data contracts and strategic human-in-the-loop (HITL) checkpoints to safeguard scientific validity at high-uncertainty decision boundaries. Operating on the design principle of ``free-form reasoning for safe tasks, structured execution for long-horizon pipelines,'' Mozi provides built-in robustness mechanisms and trace-level audibility to completely mitigate error accumulation. We evaluate Mozi on PharmaBench, a curated benchmark for biomedical agents, demonstrating superior orchestration accuracy over existing baselines. Furthermore, through end-to-end therapeutic case studies, we demonstrate Mozi's ability to navigate massive chemical spaces, enforce stringent toxicity filters, and generate highly competitive in silico candidates, effectively transforming the LLM from a fragile conversationalist into a reliable, governed co-scientist.